Research Directory

The Case for HTA co-operation

Read more

Commentary: How are regulators are supporting innovation?

Read more

Revolution afoot for allergy therapies

Read more

A scenario for shortening drug development times

Read more

Big Pharma meets Big Data

Read more

Why the UK is building cell therapy capacity

Read more

Commentary: European IPOs produce surprises

Read more

European biotechs rise in March quarter

Read more

The case for allogeneic cell therapy

Read more

Clinical and market issues for cell-based therapies

Read more